FdaApplication

ANDA 212765

Back to search

Identifiers

Properties

PropertyValue
applicant_nameADAPTIS PHARMA PRIVATE LTD
application_typeANDA
approval_date2020-08-10

Products (2)

ProductActive ingredientStrengthDosage form
EPLERENONEEPLERENONE50MGTABLET;ORAL
EPLERENONEEPLERENONE25MGTABLET;ORAL

2 products